Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1967 Sep 9;3(5566):630–631.

Chlorpromazine melanosis.

PMCID: PMC1842940  PMID: 6038332

Full text

PDF
630

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAN T. A., LEHMANN H. E., GALLAI Z., WARNES H., LEE H. RAPPORT ENTRE LA PHOTOSENSIBILIT'E ET LA PIGMENTATION PATHOLOGIQUE DE LA PEAU AVEC DES DOSES 'ELEV'EES DE CHLORPROMAZINE. Union Med Can. 1965 Mar;94:305–307. [PubMed] [Google Scholar]
  2. Barnes G. J., Cameron M. E. Skin and eye changes associated with chlorpromazine therapy. Med J Aust. 1966 Mar 19;1(12):478–481. doi: 10.5694/j.1326-5377.1966.tb72519.x. [DOI] [PubMed] [Google Scholar]
  3. CAIRNS R. J., CAPOORE H. S., GREGORY I. D. OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE. Lancet. 1965 Jan 30;1(7379):239–241. doi: 10.1016/s0140-6736(65)91524-2. [DOI] [PubMed] [Google Scholar]
  4. Cameron M. E. Ocular melanosis with special reference to chlorpromazine. Br J Ophthalmol. 1967 May;51(5):295–305. doi: 10.1136/bjo.51.5.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DELONG S. L., POLEY B. J., MCFARLANE J. R., Jr OCULAR CHANGES ASSOCIATED WITH LONG-TERM CHLORPROMAZINE THERAPY. Arch Ophthalmol. 1965 May;73:611–617. doi: 10.1001/archopht.1965.00970030613003. [DOI] [PubMed] [Google Scholar]
  6. GREINER A. C., BERRY K. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. Can Med Assoc J. 1964 Mar 14;90:663–665. [PMC free article] [PubMed] [Google Scholar]
  7. Gombos G. M., Yarden P. E. Ocular and cutaneous side effects after prolonged chlorpromazine treatment. Am J Psychiatry. 1967 Jan;123(7):872–874. doi: 10.1176/ajp.123.7.872. [DOI] [PubMed] [Google Scholar]
  8. Hashimoto K., Wiener W., Albert J., Nelson R. G. An electron microscopic study of chlorpromazine pigmentation. J Invest Dermatol. 1966 Oct;47(4):296–306. [PubMed] [Google Scholar]
  9. Henkes H. E. Fenothiazine-retinopathie. Ned Tijdschr Geneeskd. 1966 Apr 23;110(17):789–790. [PubMed] [Google Scholar]
  10. Murphy K. J. Uraemic accentuation of chlorpromazine pigmentation. Med J Aust. 1966 Dec 24;2(26):1228–1229. doi: 10.5694/j.1326-5377.1966.tb91954.x. [DOI] [PubMed] [Google Scholar]
  11. Satanove A. Pigmentation due to phenothiazines in high and prolonged dosage. JAMA. 1965 Jan 25;191(4):263–268. [PubMed] [Google Scholar]
  12. Siddall J. R. The ocular toxic findings with prolonged and high dosage chlorpromazine intake. Arch Ophthalmol. 1965 Oct;74(4):460–464. doi: 10.1001/archopht.1965.00970040462005. [DOI] [PubMed] [Google Scholar]
  13. Valentine M., Jardine P. Phenothiazines and eye complications. Br Med J. 1966 Sep 3;2(5513):586–586. doi: 10.1136/bmj.2.5513.586-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Zelickson A. S. Skin pigmentation and chlorpromazine. JAMA. 1965 Nov 8;194(6):670–672. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES